Alex Tchung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alex Tchung has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Louis-Eric Trudeau
Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada
10 shared publications - Amandine Even
Department of pharmacology and physiology, Faculty of Medicine, Université de Montréal, Québec, Canada
3 shared publications - Charles Ducrot
Interdisciplinary Institute for Neuroscience, UMR 5297, CNRS, Neurocampus Department, University of Bordeaux, Bordeaux F-33076, France
3 shared publications - Nicolas Giguère
Department of pharmacology and physiology, Faculty of Medicine, Université de Montréal, Québec, Canada
3 shared publications Catherine Lévesque
Faculty of Pharmacy, Université de Montreal, Montreal, Canada
2 shared publications- Consiglia Pacelli
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
2 shared publications
Latest Publications
- 19 May 2026
- Published by Elsevier in Neuroscience
- Vol. 609, 84-92
Neurexins contribute to inhibitory connectivity and dopamine neuron resilience in culture
- 19 May 2026
- Published by Elsevier in Neuroscience
- Vol. 609, 84-92
Neurexins contribute to inhibitory connectivity and dopamine neuron resilience in culture
- Open Access
- 21 April 2026
- Published by Springer Nature
Semi-automated quantification of microglial CD68 and Iba1 immunohistochemistry signal in mouse brain slices v1
Standardized procedure for semi-automated detection and quantification of CD68 and Iba1 in floating brain sections, using image acquisition, AI-based segmentation, and downstream data analysis.
- 21 April 2026
- Published by Springer Nature
Open AccessSemi-automated quantification of microglial CD68 and Iba1 immunohistochemistry signal in mouse brain slices v1
Standardized procedure for semi-automated detection and quantification of CD68 and Iba1 in floating brain sections, using image acquisition, AI-based segmentation, and downstream data analysis.
- Open Access
- 21 April 2026
- Published by Springer Nature
Confocal imaging and image processing with ImageJ v1
This protocol describes confocal imaging using a confocal microscope and subsequent image processing with ImageJ, as well as data compilation. The workflow includes quantitative analysis of microglial cell count and morphology, Iba1 fluorescence intensity, and assessment of astrocyte area and GFAP intensity. It also includes analysis of tyrosine hydroxylase (TH) and dopamine transporter (DAT) expression.
- 21 April 2026
- Published by Springer Nature
Open AccessConfocal imaging and image processing with ImageJ v1
This protocol describes confocal imaging using a confocal microscope and subsequent image processing with ImageJ, as well as data compilation. The workflow includes quantitative analysis of microglial cell count and morphology, Iba1 fluorescence intensity, and assessment of astrocyte area and GFAP intensity. It also includes analysis of tyrosine hydroxylase (TH) and dopamine transporter (DAT) expression.
- Open Access
- 21 April 2026
- Published by Springer Nature
Automated Quantification of Dopaminergic Neurons in Floating Sections v1
Standardized procedure for automated detection and quantification of dopaminergic neurons in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in floating brain sections using image acquisition, AI-based segmentation, and downstream data analysis.
- 21 April 2026
- Published by Springer Nature
Open AccessAutomated Quantification of Dopaminergic Neurons in Floating Sections v1
Standardized procedure for automated detection and quantification of dopaminergic neurons in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in floating brain sections using image acquisition, AI-based segmentation, and downstream data analysis.
- Open Access
- 12 March 2026
- Published by Elsevier in Trends in Neurosciences
- Vol. 49 (5) , 328-343
Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
- 12 March 2026
- Published by Elsevier in Trends in Neurosciences
- Vol. 49 (5) , 328-343
Open AccessCell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease
- Open Access
Loss of neurexins disrupts inhibitory connectivity and increases vulnerability of dopamine neurons in culture
Midbrain dopamine (DA) neurons are essential regulators of basal ganglia function. Their axonal structure is intricate, with numerous non-synaptic release sites and fewer synaptic terminals that notably release glutamate or GABA. Despite their significance, the molecular mechanisms governing DA neuron connectivity and neurochemical identity remain poorly understood. We hypothesize that trans-synaptic cell adhesion molecules such as neurexins (Nrxns) regulate the interactions of DA neuron axons with target cells and thereby influence axonal branching and synapse formation by DA neurons. We therefore examined neuronal survival, axonal growth and synapse formation in cultured DA neurons lacking all neurexins (DAT::NrxnsKO). Conditional deletion of all Nrxns in DA neurons revealed that loss of Nrxns does not disrupt the basic development of these neurons or the structure of their axonal terminals, including normal expression of the vesicular monoamine transporter (VMAT2) and the calcium sensor synaptotagmin 1 (Syt1). However, loss of Nrxns affects the survival of DA neurons and their formation of inhibitory synapses, suggesting that Nrxns regulate the axonal connectivity of these neurons.
Open AccessLoss of neurexins disrupts inhibitory connectivity and increases vulnerability of dopamine neurons in culture
Midbrain dopamine (DA) neurons are essential regulators of basal ganglia function. Their axonal structure is intricate, with numerous non-synaptic release sites and fewer synaptic terminals that notably release glutamate or GABA. Despite their significance, the molecular mechanisms governing DA neuron connectivity and neurochemical identity remain poorly understood. We hypothesize that trans-synaptic cell adhesion molecules such as neurexins (Nrxns) regulate the interactions of DA neuron axons with target cells and thereby influence axonal branching and synapse formation by DA neurons. We therefore examined neuronal survival, axonal growth and synapse formation in cultured DA neurons lacking all neurexins (DAT::NrxnsKO). Conditional deletion of all Nrxns in DA neurons revealed that loss of Nrxns does not disrupt the basic development of these neurons or the structure of their axonal terminals, including normal expression of the vesicular monoamine transporter (VMAT2) and the calcium sensor synaptotagmin 1 (Syt1). However, loss of Nrxns affects the survival of DA neurons and their formation of inhibitory synapses, suggesting that Nrxns regulate the axonal connectivity of these neurons.
- Open Access
A single Citrobacter rodentium infection in Pink1 knockout and wildtype mice leads to regional blood-brain-barrier perturbation and limited microglial activation without dopamine neuron axon terminal loss
A growing body of research suggests a link between immune system activation and the development of Parkinson’s disease (PD). Previous work showed that repeated gastrointestinal infection with Citrobacter rodentium can induce PD-like motor dysfunction in Pink1 knockout (KO) mice, along with immune cell infiltration into the brain. To better understand mechanisms underlying immune-mediated brain attack in this model, we tested whether mild infections are sufficient to increase blood-brain barrier (BBB) permeability and trigger brain inflammation. Pink1 wild-type (WT) and KO mice were infected with C. rodentium , and gadolinium-enhanced magnetic resonance imaging (MRI) was performed at days 13 and 26 post-infection to assess BBB integrity. Quantitative MRI analysis revealed increased BBB permeability at day 26 in both WT and KO mice, particularly in the striatum, dentate gyrus, somatosensory cortex, and thalamus. Notably, this permeability was not associated with changes in tight junction protein expression or dopamine system markers in the striatum at either time point. However, persistent microglial activation was observed at day 26 post-infection, along with elevated levels of inflammatory mediators such as eotaxin, IFN-γ, CXCL9, IL-17, and MIP-2 in the striatum. Additionally, serum levels of IL-17 and CXCL1 were increased in infected Pink1 KO mice. Flow cytometry revealed neutrophil infiltration in the brain at day 26 post-infection. Finally, a bulk RNA-seq transcriptome analysis revealed that gene sets related to synaptic function were particularly influenced by the infection and that inflammation-related genes were upregulated by the infection in the Pink1 KO mice. These findings support the hypothesis that even mild gastrointestinal infections can increase BBB permeability, disrupt brain homeostasis, and promote chronic neuroinflammation. In genetically susceptible individuals, such as those with Pink1 deficiency, this may represent a first hit that contributes to subsequent induction of PD pathology with aging. Author summary: We hypothesize that immune system activation is linked to the development of Parkinson’s disease (PD). Previous work revealed that repeated gastrointestinal infections with Citrobacter rodentium causes PD-like symptoms and immune cell invasion in the brain of Pink1 knockout (KO) mice. In the current study, we tested whether a single mild gut infection alters blood-brain barrier (BBB) permeability and causes brain inflammation. We infected Pink1 WT and KO mice with Citrobacter rodentium and used gadolinium-enhanced MRI to detect BBB permeability changes at 13- and 26-days post-infection. Results showed increased BBB permeability in specific brain regions at 26 days. While tight-junction and dopamine (DA)-related proteins remained unchanged, we observed altered expression of synaptic genes, chronic microglial activation, elevated inflammatory markers, and neutrophil infiltration in the brain. Our findings suggest that even mild gastrointestinal infections can increase BBB permeability, potentially enabling immune cell infiltration into the brain and exacerbating pathways implicated in the development of PD, particularly among individuals with genetic risk factors.
Open AccessA single Citrobacter rodentium infection in Pink1 knockout and wildtype mice leads to regional blood-brain-barrier perturbation and limited microglial activation without dopamine neuron axon terminal loss
A growing body of research suggests a link between immune system activation and the development of Parkinson’s disease (PD). Previous work showed that repeated gastrointestinal infection with Citrobacter rodentium can induce PD-like motor dysfunction in Pink1 knockout (KO) mice, along with immune cell infiltration into the brain. To better understand mechanisms underlying immune-mediated brain attack in this model, we tested whether mild infections are sufficient to increase blood-brain barrier (BBB) permeability and trigger brain inflammation. Pink1 wild-type (WT) and KO mice were infected with C. rodentium , and gadolinium-enhanced magnetic resonance imaging (MRI) was performed at days 13 and 26 post-infection to assess BBB integrity. Quantitative MRI analysis revealed increased BBB permeability at day 26 in both WT and KO mice, particularly in the striatum, dentate gyrus, somatosensory cortex, and thalamus. Notably, this permeability was not associated with changes in tight junction protein expression or dopamine system markers in the striatum at either time point. However, persistent microglial activation was observed at day 26 post-infection, along with elevated levels of inflammatory mediators such as eotaxin, IFN-γ, CXCL9, IL-17, and MIP-2 in the striatum. Additionally, serum levels of IL-17 and CXCL1 were increased in infected Pink1 KO mice. Flow cytometry revealed neutrophil infiltration in the brain at day 26 post-infection. Finally, a bulk RNA-seq transcriptome analysis revealed that gene sets related to synaptic function were particularly influenced by the infection and that inflammation-related genes were upregulated by the infection in the Pink1 KO mice. These findings support the hypothesis that even mild gastrointestinal infections can increase BBB permeability, disrupt brain homeostasis, and promote chronic neuroinflammation. In genetically susceptible individuals, such as those with Pink1 deficiency, this may represent a first hit that contributes to subsequent induction of PD pathology with aging. Author summary: We hypothesize that immune system activation is linked to the development of Parkinson’s disease (PD). Previous work revealed that repeated gastrointestinal infections with Citrobacter rodentium causes PD-like symptoms and immune cell invasion in the brain of Pink1 knockout (KO) mice. In the current study, we tested whether a single mild gut infection alters blood-brain barrier (BBB) permeability and causes brain inflammation. We infected Pink1 WT and KO mice with Citrobacter rodentium and used gadolinium-enhanced MRI to detect BBB permeability changes at 13- and 26-days post-infection. Results showed increased BBB permeability in specific brain regions at 26 days. While tight-junction and dopamine (DA)-related proteins remained unchanged, we observed altered expression of synaptic genes, chronic microglial activation, elevated inflammatory markers, and neutrophil infiltration in the brain. Our findings suggest that even mild gastrointestinal infections can increase BBB permeability, potentially enabling immune cell infiltration into the brain and exacerbating pathways implicated in the development of PD, particularly among individuals with genetic risk factors.
- Open Access
Mitochondrial antigen-specific CD8⁺ T cells drive dopamine neuron neurodegeneration
Summary: The progressive degeneration of dopamine (DA) neurons drives motor symptoms in Parkinson’s disease (PD). Whether this neuronal degeneration is due to cell-autonomous dysfunctions in DA neurons or to death signals generated by other cell types is a key problem to address. Recent evidence suggests that loss of function of the protein PINK1, linked to early-onset forms of PD, enhances the presentation of self-derived mitochondrial antigens, which induces the response of autoreactive CD8 + T cells. Whether mitochondrial antigen-specific CD8 + T cells alone are sufficient to induce nigrostriatal dysfunction has not been directly tested. Here we performed adoptive transfer of mitochondrial antigen-specific CD8 + T cells into wild-type or PINK1-deficient mice. We provide evidence for the entry and persistence of such cells in the brain and show that this leads to levodopa-reversible motor dysfunctions and partial degeneration of the nigrostriatal DA system in both genotypes. These findings establish that brain entry of autoreactive CD8 + T cells is sufficient to drive nigrostriatal degeneration and parkinsonian motor deficits, providing the most direct support to date for the hypothesis that an adaptive immune attack plays a key role in PD-like neurodegeneration.
Open AccessMitochondrial antigen-specific CD8⁺ T cells drive dopamine neuron neurodegeneration
Summary: The progressive degeneration of dopamine (DA) neurons drives motor symptoms in Parkinson’s disease (PD). Whether this neuronal degeneration is due to cell-autonomous dysfunctions in DA neurons or to death signals generated by other cell types is a key problem to address. Recent evidence suggests that loss of function of the protein PINK1, linked to early-onset forms of PD, enhances the presentation of self-derived mitochondrial antigens, which induces the response of autoreactive CD8 + T cells. Whether mitochondrial antigen-specific CD8 + T cells alone are sufficient to induce nigrostriatal dysfunction has not been directly tested. Here we performed adoptive transfer of mitochondrial antigen-specific CD8 + T cells into wild-type or PINK1-deficient mice. We provide evidence for the entry and persistence of such cells in the brain and show that this leads to levodopa-reversible motor dysfunctions and partial degeneration of the nigrostriatal DA system in both genotypes. These findings establish that brain entry of autoreactive CD8 + T cells is sufficient to drive nigrostriatal degeneration and parkinsonian motor deficits, providing the most direct support to date for the hypothesis that an adaptive immune attack plays a key role in PD-like neurodegeneration.
- Open Access
- 11 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-24
Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice
In Parkinson’s disease (PD), motor dysfunctions only become apparent after extensive loss of DA innervation. This resilience has been hypothesized to be due to the ability of many motor behaviors to be sustained through a diffuse basal tone of DA; but experimental evidence for this is limited. Here we show that conditional deletion of the calcium sensor synaptotagmin-1 (Syt1) in DA neurons (Syt1 cKODA mice) abrogates most activity-dependent axonal DA release in the striatum and mesencephalon, leaving somatodendritic (STD) DA release intact. Strikingly, Syt1 cKODA mice showed intact performance in multiple unconditioned DA-dependent motor tasks and even in a task evaluating conditioned motivation for food. Considering that basal extracellular DA levels in the striatum were unchanged, our findings suggest that activity-dependent DA release is dispensable for such tasks and that they can be sustained by a basal tone of extracellular DA. Taken together, our findings reveal the striking resilience of DA-dependent motor functions in the context of a near-abolition of phasic DA release, shedding new light on why extensive loss of DA innervation is required to reveal motor dysfunctions in PD.
- 11 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-24
Open AccessSynaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice
In Parkinson’s disease (PD), motor dysfunctions only become apparent after extensive loss of DA innervation. This resilience has been hypothesized to be due to the ability of many motor behaviors to be sustained through a diffuse basal tone of DA; but experimental evidence for this is limited. Here we show that conditional deletion of the calcium sensor synaptotagmin-1 (Syt1) in DA neurons (Syt1 cKODA mice) abrogates most activity-dependent axonal DA release in the striatum and mesencephalon, leaving somatodendritic (STD) DA release intact. Strikingly, Syt1 cKODA mice showed intact performance in multiple unconditioned DA-dependent motor tasks and even in a task evaluating conditioned motivation for food. Considering that basal extracellular DA levels in the striatum were unchanged, our findings suggest that activity-dependent DA release is dispensable for such tasks and that they can be sustained by a basal tone of extracellular DA. Taken together, our findings reveal the striking resilience of DA-dependent motor functions in the context of a near-abolition of phasic DA release, shedding new light on why extensive loss of DA innervation is required to reveal motor dysfunctions in PD.
- Open Access
Synaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice
In Parkinson’s disease (PD), motor dysfunctions only become apparent after extensive loss of DA innervation. This resilience has been hypothesized to be due to the ability of many motor behaviors to be sustained through a diffuse basal tone of DA; but experimental evidence for this is limited. Here we show that conditional deletion of the calcium sensor synaptotagmin-1 (Syt1) in DA neurons (Syt1 cKO DA mice) abrogates most activity-dependent axonal DA release in the striatum and mesencephalon, leaving somatodendritic (STD) DA release intact. Strikingly, Syt1 cKO DA mice showed intact performance in multiple unconditioned DA-dependent motor tasks and even in a task evaluating conditioned motivation for food. Considering that basal extracellular DA levels in the striatum were unchanged, our findings suggest that activity-dependent DA release is dispensable for such tasks and that they can be sustained by a basal tone of extracellular DA. Taken together, our findings reveal the striking resilience of DA-dependent motor functions in the context of a near-abolition of phasic DA release, shedding new light on why extensive loss of DA innervation is required to reveal motor dysfunctions in PD.
Open AccessSynaptotagmin-1-dependent phasic axonal dopamine release is dispensable for basic motor behaviors in mice
In Parkinson’s disease (PD), motor dysfunctions only become apparent after extensive loss of DA innervation. This resilience has been hypothesized to be due to the ability of many motor behaviors to be sustained through a diffuse basal tone of DA; but experimental evidence for this is limited. Here we show that conditional deletion of the calcium sensor synaptotagmin-1 (Syt1) in DA neurons (Syt1 cKO DA mice) abrogates most activity-dependent axonal DA release in the striatum and mesencephalon, leaving somatodendritic (STD) DA release intact. Strikingly, Syt1 cKO DA mice showed intact performance in multiple unconditioned DA-dependent motor tasks and even in a task evaluating conditioned motivation for food. Considering that basal extracellular DA levels in the striatum were unchanged, our findings suggest that activity-dependent DA release is dispensable for such tasks and that they can be sustained by a basal tone of extracellular DA. Taken together, our findings reveal the striking resilience of DA-dependent motor functions in the context of a near-abolition of phasic DA release, shedding new light on why extensive loss of DA innervation is required to reveal motor dysfunctions in PD.